(89)Zr-Chloride Can Be Used for Immuno-PET Radiochemistry Without Loss of Antigen Reactivity In Vivo

(89)Zr immuno-PET continues to be assessed in numerous clinical trials. This report evaluates the use of (89)Zr-chloride in the radiolabeling of monoclonal antibodies conjugated with desferrioxamine B (DFO), describes its effects on radiopharmaceutical reactivity toward antigen, and offers guidance...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Nucl Med
Päätekijät: Pandya, Darpan N., Bhatt, Nikunj B., Almaguel, Frankis, Rideout-Danner, Stephanie, Gage, Howard D., Solingapuram Sai, Kiran Kumar, Wadas, Thaddeus J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Society of Nuclear Medicine 2019
Aiheet:
Radiochemistry
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6495241/
https://ncbi.nlm.nih.gov/pubmed/30442753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.216457
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia